CVE-2008-5233: xine xine-lib
Vulnerability summary
CVE-2008-5233 is a medium (CVSS 4.3) vulnerability in xine xine-lib. EPSS estimates a 3.35% chance of exploitation in the next 30 days, higher than 88.5% of scored vulnerabilities.
Timeline
- 26-11-2008PublishedVulnerability first disclosed.
- 07-08-2024Last modifiedVulnerability information updated.
Description
xine-lib 1.1.12, and other versions before 1.1.15, does not check for failure of malloc in circumstances including (1) the mymng_process_header function in demux_mng.c, (2) the open_mod_file function in demux_mod.c, and (3) frame_buffer allocation in the real_parse_audio_specific_data function in demux_real.c, which allows remote attackers to cause a denial of service (crash) or possibly execute arbitrary code via a crafted media file.
CVSS metrics
1 score · 1 source · 1 versionEPSS trend
Probability
3.35%
Chance of exploitation in the next 30 days
Percentile
89%
Versus all other CVEs
30-day change
0.00 pp
From 3.35% on 21-09-2026
Known exploited
Compare KEV catalogsNot in any of the 3 tracked catalogs.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root causeAffected systems
Xine1 product
- xine-lib≤ 1.1.14 | 0.9.13 | 1:rc0a | 1:rc1 | 1:rc2 | 1:rc3 | 1:rc3a | 1:rc3b | 1:rc3c | 1:rc4 | 1:rc4a | 1:rc5 | 1:rc6a | 1:rc7 | 1:rc8 | 1.0 | 1.0.1 | 1.0.2 | 1.0.3a | 1.1.0 | 1.1.1 | 1.1.2 | 1.1.3 | 1.1.4 | 1.1.5 | 1.1.6 | 1.1.7 | 1.1.8 | 1.1.9 | 1.1.9.1 | 1.1.10 | 1.1.10.1 | 1.1.11 | 1.1.11.1 | 1.1.12 | 1.1.13 | 1_beta1 | 1_beta2 | 1_beta3 | 1_beta4 | 1_beta5 | 1_beta6 | 1_beta7 | 1_beta8 | 1_beta9 | 1_beta10 | 1_beta11 | 1_beta12
1 vendor · 1 product
References
15 links- www.ocert.org/analysis/2008-008/analysis.txtX Refsource MISC
- www.redhat.com/archives/fedora-package-announce/2008-September/msg00174.htmlVendor AdvisoryX Refsource FEDORA
Show all 15 references
- www.redhat.com/archives/fedora-package-announce/2008-September/msg00385.htmlVendor AdvisoryX Refsource FEDORA
- sourceforge.net/project/shownotes.php?release_id=619869X Refsource CONFIRM